Freya Meds offers more than one answer to the question “What does treatment cost?” Its homepage advertises semaglutide starting as low as $150 per month and tirzepatide starting as low as $249. The treatment pages show higher figures, with different rates for monthly plans and quarterly billing. For someone comparing cash-pay programs, the important task is not choosing the smallest number. It is identifying which offer applies, what gets charged first and what that payment actually buys.
This review examines Freya’s public pages and legal documents consulted October 19, 2026. Freya describes an online weight-management program connecting patients with clinicians for possible prescriptions and home delivery. Its documents also distinguish the administrative platform from independent clinical providers. The offering includes substantial advertised support, but unresolved pricing conditions, cancellation details and conflicting geographic statements make a written, patient-specific quote especially important. Nothing in these materials guarantees a prescription or establishes an individual treatment outcome.
At a glance
- Homepage starting prices
- Semaglutide starts as low as $150 per month and tirzepatide as low as $249; the conditions for those minimums are not explained in the supplied material.Sources: [2]
- Treatment-page prices
- Semaglutide is advertised at $250 per month billed and delivered quarterly, or $297 for monthly plans. Tirzepatide is $332 per month billed and delivered quarterly, or $390 for monthly plans.
- Payment model
- The terms describe cash-pay services, with no commercial insurance acceptance or participation in Medicare or Medicaid.Sources: [5]
- Cancellation boundary
- Treatment pages advertise cancellation at any time, but the supplied documents do not establish refund rights, renewal deadlines or treatment of quarterly prepayments.
Start with the charge, not the headline
Freya’s lowest advertised figures are starting prices, not documented universal rates. The homepage lists semaglutide starting as low as $150 monthly and tirzepatide starting as low as $249 monthly. Neither figure comes with enough detail in the supplied material to establish the qualifying plan, product presentation or payment arrangement. A buyer should therefore treat these as advertised entry points requiring confirmation, rather than assume either amount will appear at checkout.
The treatment pages give a more concrete comparison: semaglutide at $250 per month with quarterly billing and delivery, versus $297 on a monthly plan; tirzepatide at $332 per month with quarterly billing and delivery, versus $390 monthly. Quarterly billing is an alternative to the monthly option, not a requirement imposed on every customer. The monthly equivalent on a quarterly plan should not be mistaken for a promise of monthly collection.
A homepage banner also advertises up to $272 off three-month plans at checkout, ending October 31 without stating a year. Its current applicability cannot be established from that wording. The supplied pages do not reconcile the promotion, homepage minimums and treatment-page rates, or document subsequent charges after any discount. Our guide to understanding the first payment explains why the initial checkout amount deserves separate attention from a monthly headline.
| Offer | Advertised amount | Condition or unresolved detail |
|---|---|---|
| Homepage semaglutide | Starting as low as $150 per month | Conditions for the minimum are not specified |
| Homepage tirzepatide | Starting as low as $249 per month | Conditions for the minimum are not specified |
| Treatment-page semaglutide | $250 per month quarterly; $297 monthly | The $250 rate is billed and delivered quarterly |
| Treatment-page tirzepatide | $332 per month quarterly; $390 monthly | The $332 rate is billed and delivered quarterly |
| Three-month promotion | Up to $272 off at checkout | Ends October 31; year and applicability are unconfirmed |
What Freya says the payment includes
Freya describes payment as covering a full monthly treatment plan rather than a particular vial, and says the cost stays the same regardless of the dose the clinician determines. That is a meaningful pricing claim, but it does not identify the exact formulation, route, presentation or quantity dispensed. References to syringes and vials do not resolve those product details. A written quote should name the actual prescription product instead of relying only on the ingredient name.
The homepage says the price “usually includes” medication, syringes, shipping, consultations and support. That qualifier matters. More specifically, the treatment-page package lists medication, unlimited doctor consultations, monthly group calls and a one-on-one consultation with Freya’s dietitian. The homepage also advertises monthly expert sessions with questions and answers, plus unlimited clinician and care-team access. These are advertised package features, not independently verified measures of how often patients receive or use them.
The legal terms are broader about financial responsibility: users are responsible for associated professional, laboratory and pharmacy fees, and third parties process payments. This does not prove that every listed service produces a separate bill, but it prevents treating the marketing bundle as a complete fee schedule. Required laboratory testing and its price remain unconfirmed. Use the distinction between included services and additional costs to request explicit answers before paying.
Monthly flexibility does not settle quarterly refunds
Freya’s homepage advertises month-to-month care with no membership fees, no lock-in and no waitlists. The treatment pages say “Cancel anytime,” while also offering plans billed and delivered quarterly. Those statements can describe different purchasing options, but they leave an important financial question unresolved: what happens to money already collected for a quarterly plan if someone cancels before its billing period ends? Permission to cancel is not, by itself, a promise to refund.
The supplied material does not establish an automatic-renewal schedule, cancellation procedure, advance-notice deadline or refund policy. It also does not explain whether a payment is returned when a clinician declines to prescribe. A three-month package description does not independently establish a minimum treatment commitment or exact medication quantity. Before choosing quarterly billing, request the actual collection schedule and the policy governing unused prepaid services, not simply confirmation that cancellation is allowed.
Freya’s treatment-page slogan also promises no hidden fees, lock-ins or price changes. That advertising should be read alongside the unresolved relationship between its published rates, rather than as a fully specified renewal-price guarantee. Ask what the next charge will be, when it occurs and which written terms govern it. Our explanation of cancellation versus refunds is particularly relevant when a program offers both monthly flexibility and quarterly collection.
Cash payment and location are early decision points
Freya’s terms state that neither the platform nor its affiliated clinical entities accepts commercial health insurance or participates in Medicare or Medicaid. Users obtain services on a cash-pay basis. This describes the service’s payment model; it does not establish a general rule about an individual’s eligibility based on insurance enrollment. Nor does it establish reimbursement rights. Anyone budgeting around insurance should distinguish Freya’s nonacceptance from whatever their own plan might separately cover.
Geography presents a sharper contradiction. The homepage advertises more than 450,000 patients across all 50 U.S. states, but the terms say services are unavailable in Alabama, Mississippi and West Virginia and that residents cannot complete checkout. The terms also limit service use to people located in the United States. The nationwide marketing statement should therefore not be treated as confirmation of current availability everywhere, and the patient count remains a provider claim.
The practical order is to confirm availability before comparing payment options or sharing extensive intake information. Then ask for the full cash-pay amount, including any required services outside the advertised package. Our guide to insurance and self-pay questions separates program payment from insurance coverage. Freya’s documentation supports a direct-pay model, but it does not supply enough information to promise that a customer can recover those charges elsewhere.
Who evaluates the patient—and who operates the platform
Freya advertises a confidential initial assessment covering health, goals and lifestyle, with no commitment required. Its homepage describes an online program connecting patients with licensed doctors for possible semaglutide or tirzepatide prescriptions, including advertised same-day prescription review. Eligibility depends on a clinician reviewing medical history, current medicines, weight goals and the overall medical profile. Not everyone qualifies, and a same-day review claim does not establish same-day shipment, arrival or guaranteed prescribing.
The legal structure is more specific than the consumer-facing description. The terms identify FREYA MEDS International Inc. and affiliates, although the document heading uses FREYA MEDS INC. They describe Freya as a nonclinical administrative and technology provider for independent professional corporations, not an organization practicing medicine or employing or contracting with clinicians to deliver clinical services. Diagnosis, treatment and prescribing belong to the independent licensed professional working through an affiliated entity.
The intended users are adults 18 or older. The semaglutide page mentions adults who have struggled with diet and exercise and describes BMI of 27 or above as a favorable profile; that is not a complete eligibility standard. The supplied materials do not name the affiliated professional corporations or responsible clinicians. Before paying, useful questions include which clinical entity will provide care, who will evaluate the intake and what financial policy applies if treatment is not prescribed.
The product and pharmacy still need identification
Freya’s terms contemplate compounded medications when a prescribing professional considers them appropriate, but the sample does not identify the exact product supplied under each advertised price. It also does not name dispensing pharmacies. The terms allow use of a partner pharmacy and allow a patient-selected pharmacy when that option is presented during the service. That conditional alternative is not an unrestricted promise that every prescription can be filled anywhere at the same package price.
FDA guidance supplies an important distinction for comparing these offers. Compounded preparations are not FDA approved and do not receive FDA premarket review for safety, effectiveness and quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not demonstrate clinical inequivalence. Approval attaches to a specific product, not to Freya as a platform or to a dispensing pharmacy.
For cost comparison, the missing product identity is consequential: ingredient names alone do not establish equivalent purchases. Freya’s terms also disclaim guarantees about compounded medication safety, efficacy, purity and quality. Those disclaimers are not evidence of a particular defect, but neither are promotional ingredient comparisons proof of equivalence to a branded drug. Request the formulation, route, presentation, dispensing pharmacy and whether the prescription is compounded before treating any listed price as a like-for-like alternative.
Delivery promises leave several practical gaps
Freya advertises free, discreet shipping and uses the phrase “Fast 3 Day Shipping” on treatment pages. The latter does not specify when the clock starts or whether it describes dispatch, transit or arrival. Quarterly plans separately state that delivery is quarterly, unlike the homepage’s general description of monthly medication delivery. These are reasons to confirm the chosen plan’s shipping cadence, not evidence that a package will arrive three days after an assessment or payment.
The tirzepatide page describes medication as properly stored and delivered ready to use, but the supplied material does not explain packaging, temperature controls, carrier, tracking, replacement procedures or a complete payment-to-arrival timeline. The terms add a concrete household consideration: medication fulfilled through Freya’s pharmacy network will not arrive in child-resistant packaging and must be kept away from children. These details matter independently of whether shipping has a separate charge.
For an injectable GLP-1 product that arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That guidance is not an allegation about Freya’s deliveries. It highlights why a documented delivery-problem process belongs in the purchasing decision. Ask which organization handles a compromised package and whether replacement creates an additional charge; the supplied sources do not settle either question.
Follow-up is part of the value proposition
Freya advertises continuity with the same doctor, weekly check-ins and adjustments, and messaging access to the practitioner familiar with the case. Additional resources include nutrition plans, meal guidance, lifestyle coaching, habit-building tools and progress tracking through a personalized dashboard. These distinguish its advertised service from a medication-only purchase. However, the sample does not establish guaranteed response times or explain how the different weekly, monthly and on-demand support channels operate together.
The semaglutide page directs patients to contact their practitioner if something feels wrong, with the professional deciding whether to change the approach. General inquiries can go to contact@freyameds.com; the privacy policy lists hours of 8 a.m. to 8 p.m. Eastern, Monday through Sunday, and an address at 30 N Gould St Ste R, Sheridan, Wyoming 82801. Those published contact hours should not be read as a guaranteed clinical response window. Emergency care is expressly outside the service.
For continuity elsewhere, the terms describe requesting transfer of a telehealth record through doctor@freyameds.com with consent and the receiving provider’s name, address and phone number. The privacy policy also describes access, correction, deletion and certain processing restrictions subject to applicable law. These are useful documented paths, although Spanish-language care and accessibility arrangements are not confirmed. Before enrollment, ask how support continues during cancellation, a pharmacy delay or a transfer to another clinician.
Questions & answers
Can I assume Freya semaglutide will cost $150 each month?
No. That is the homepage’s starting-as-low-as figure, with qualifying conditions unresolved. The semaglutide treatment page instead lists $250 per month billed and delivered quarterly, or $297 for monthly plans. Ask which offer applies to you, the amount collected initially and the charge after any promotion. The supplied material does not reconcile these prices or identify the exact product behind every offer.
Does Freya require everyone to pay quarterly?
No. Both treatment pages advertise monthly options alongside quarterly billing and delivery. The quarterly rates are expressed as monthly equivalents, not described as monthly collection. Before selecting one, confirm the checkout charge, delivery schedule and future billing dates. A quarterly plan description alone does not establish the exact medication quantity supplied or what happens financially if treatment ends during that period.
Will canceling Freya automatically produce a refund?
The supplied documents do not establish that. Treatment pages advertise cancellation at any time, but no documented refund rules explain quarterly prepayments, unused services or a declined prescription. The cancellation method and advance-notice deadline are also unconfirmed. Obtain those terms before paying, particularly if choosing quarterly billing; stopping future service and recovering an earlier payment are separate questions.
Are Freya’s consultations and nutrition services included?
The treatment-page package lists unlimited doctor consultations, monthly group calls and one one-on-one dietitian consultation. Other pages advertise messaging, nutrition guidance and care-team access. However, the homepage says costs “usually” include medication, supplies, shipping and consultations, while the terms assign responsibility for associated fees to users. Confirm the exact package and any laboratory or pharmacy charges rather than assuming every possible service is included.
Can residents of all 50 states use Freya?
The documents do not support that conclusion. Although the homepage advertises patients across all 50 states, the terms expressly exclude Alabama, Mississippi and West Virginia and say residents cannot complete checkout. Services are otherwise intended for people located in the United States. Confirm current availability directly, but do not treat the nationwide marketing statement as overriding the specific exclusions.
Can I choose a pharmacy outside Freya’s network?
The terms permit a pharmacy of your choice when that option is presented during use of the service. They also describe fulfillment through partner pharmacies. This is a conditional choice, not a guarantee for every prescription or plan. Ask whether outside fulfillment is available for your prescription, how the quoted package changes and whether the pharmacy will bill separately. The supplied materials do not name the dispensing partners.
Our assessment
Freya documents a potentially useful bundle: clinician access, nutrition support, messaging and home delivery, with both monthly and quarterly purchasing options. Its stated plan-based pricing could simplify budgeting once the applicable offer is identified. The weakness is that the public materials do not yet produce a complete, internally consistent purchasing picture. Homepage minimums differ from treatment-page rates; refund and renewal rules remain unresolved; and product and pharmacy identities need confirmation. A reasonable next step is a written quote naming the product, initial charge, subsequent billing, included services and cancellation consequences. Freya merits consideration as a documented cash-pay telehealth offering, but its lowest advertised price alone is not enough to establish affordability or value.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.